Protective effect of pirfenidone against ovarian ischemia/reperfusion injury in rats via modulation of TLR4/p38 MAPK/IL-1β and HIF-1α/VEGF-A signaling pathways
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Asmaa Mohamed Abdel-Aziz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Minia University, Minia 61511, Egypt. Hauptthemen laut MEDLINE: Reperfusion Injury, Ovary, Pyridones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Objective
Ovarian ischemia/reperfusion (I/R) injury is a common gynecological emergency, typically caused by ovarian torsion. Pirfenidone (PFN) has demonstrated potential therapeutic benefits due to its antioxidant, anti-inflammatory, and antiapoptotic properties. This research aimed to investigate the protective effects of PFN in alleviating ovarian I/R injury in female rats.
Methods
Female rats received PFN (300 mg/kg/day) for 3 consecutive days, either with or without the induction of ovarian I/R. The study assessed markers of ovarian oxidative stress, inflammation, apoptosis, and the levels of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor-A (VEGF-A). Ovarian histology was analyzed, along with immunohistochemical staining for Toll-like receptor 4 (TLR4) and p38 mitogen-activated protein kinase (p38 MAPK). Key findings I/R injury resulted in increased oxidative stress, inflammation, apoptosis, and a significant reduction in ovarian VEGF-A levels. Histological examination revealed ovarian damage, with increased expression of TLR4 and p38 MAPK. PFN treatment significantly improved the hormonal balance and mitigated oxidative stress, inflammatory, and apoptotic markers to normal levels. In addition, PFN improved ovarian tissue morphology and decreased TLR4 and p38 MAPK expression.
Conclusions
The findings suggest that PFN may offer protective effects against ovarian I/R injury through its antioxidant, anti-inflammatory, and antiapoptotic properties, as well as by promoting angiogenesis in the ovary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Pharmacology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
- Department of Pathology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
- Department of Microbiology and Immunology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
- Department of Human Anatomy and Embryology, Faculty of Medicine, Minia University, Minia 61511, Egypt.
- Department of Medical Biochemistry, Faculty of Medicine, Minia University, Minia 61511, Egypt.
ORCID-Profile: Asmaa Mohamed Abdel-Aziz
Zitieren
APA
Abdel-Aziz, A. M., Hassan, M., Thabit, D. M., Said, S., Shawky, H. A., Elsayed, S. H., & Khalaf, H. M. (2025). Protective effect of pirfenidone against ovarian ischemia/reperfusion injury in rats via modulation of TLR4/p38 MAPK/IL-1β and HIF-1α/VEGF-A signaling pathways. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf066
Vancouver
Abdel-Aziz AM, Hassan M, Thabit DM, Said S, Shawky HA, Elsayed SH, et al. Protective effect of pirfenidone against ovarian ischemia/reperfusion injury in rats via modulation of TLR4/p38 MAPK/IL-1β and HIF-1α/VEGF-A signaling pathways. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf066
BibTeX
@article{AbdelAziz2025,
author = {Abdel-Aziz, Asmaa Mohamed and Hassan, Marwa and Thabit, Dina Moustafa and Said, Safaa and Shawky, Heba A and Elsayed, Samar Hisham and Khalaf, Hanaa Mohamed},
title = {Protective effect of pirfenidone against ovarian ischemia/reperfusion injury in rats via modulation of TLR4/p38 MAPK/IL-1β and HIF-1α/VEGF-A signaling pathways},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf066}
}
EUVIMED